These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 20163388)
21. Factor mixture analysis of paranoia in young people. Preti A; Massidda D; Cella M; Raballo A; Scanu R; Tronci D; Gabbrielli M; Muratore T; Carta MG; Petretto DR Soc Psychiatry Psychiatr Epidemiol; 2019 Mar; 54(3):355-367. PubMed ID: 30542959 [TBL] [Abstract][Full Text] [Related]
22. Differences in clinical features and gut microbiota between individuals with methamphetamine casual use and methamphetamine use disorder. He L; Yang BZ; Ma YJ; Wen L; Liu F; Zhang XJ; Liu TQ Front Cell Infect Microbiol; 2023; 13():1103919. PubMed ID: 36909722 [TBL] [Abstract][Full Text] [Related]
23. The persecutory ideation questionnaire. McKay R; Langdon R; Coltheart M J Nerv Ment Dis; 2006 Aug; 194(8):628-31. PubMed ID: 16909074 [TBL] [Abstract][Full Text] [Related]
24. Qualitatively distinct factors contribute to elevated rates of paranoia in autism and schizophrenia. Pinkham AE; Sasson NJ; Beaton D; Abdi H; Kohler CG; Penn DL J Abnorm Psychol; 2012 Aug; 121(3):767-777. PubMed ID: 22686868 [TBL] [Abstract][Full Text] [Related]
25. The impact of comorbid cannabis and methamphetamine use on mental health among regular ecstasy users. Scott LA; Roxburgh A; Bruno R; Matthews A; Burns L Addict Behav; 2012 Sep; 37(9):1058-62. PubMed ID: 22607716 [TBL] [Abstract][Full Text] [Related]
26. A retrospective review of trends and clinical characteristics of methamphetamine-related acute psychiatric admissions in a South African context. Vos PJ; Cloete KJ; le Roux A; Kidd M; Jordaan GP Afr J Psychiatry (Johannesbg); 2010 Nov; 13(5):390-4. PubMed ID: 21390410 [TBL] [Abstract][Full Text] [Related]
27. Paranoia in African-American men receiving inpatient psychiatric treatment. Whaley AL J Am Acad Psychiatry Law; 2004; 32(3):282-90. PubMed ID: 15515917 [TBL] [Abstract][Full Text] [Related]
28. Personality traits and mental health states of methamphetamine-dependent and methamphetamine non-using MSM. Solomon TM; Kiang MV; Halkitis PN; Moeller RW; Pappas MK Addict Behav; 2010 Feb; 35(2):161-3. PubMed ID: 19786324 [TBL] [Abstract][Full Text] [Related]
29. Virtual reality study of paranoid thinking in the general population. Freeman D; Pugh K; Antley A; Slater M; Bebbington P; Gittins M; Dunn G; Kuipers E; Fowler D; Garety P Br J Psychiatry; 2008 Apr; 192(4):258-63. PubMed ID: 18378984 [TBL] [Abstract][Full Text] [Related]
30. Relationship between methamphetamine use history and segmental hair analysis findings of MA users. Han E; Lee S; In S; Park M; Park Y; Cho S; Shin J; Lee H Forensic Sci Int; 2015 Sep; 254():59-67. PubMed ID: 26197349 [TBL] [Abstract][Full Text] [Related]
31. Clinical course and outcomes of methamphetamine-dependent adults with psychosis. Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R; J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802 [TBL] [Abstract][Full Text] [Related]
32. Profile of psychiatric symptoms in methamphetamine users in China: Greater risk of psychiatric symptoms with a longer duration of use. Ma J; Sun XJ; Wang RJ; Wang TY; Su MF; Liu MX; Li SX; Han Y; Meng SQ; Wu P; Shi J; Bao YP; Lu L Psychiatry Res; 2018 Apr; 262():184-192. PubMed ID: 29453037 [TBL] [Abstract][Full Text] [Related]
33. Measuring ideas of persecution and social reference: the Green et al. Paranoid Thought Scales (GPTS). Green CE; Freeman D; Kuipers E; Bebbington P; Fowler D; Dunn G; Garety PA Psychol Med; 2008 Jan; 38(1):101-11. PubMed ID: 17903336 [TBL] [Abstract][Full Text] [Related]
34. Leukocyte telomere length is not shortened in methamphetamine dependence or methamphetamine-induced psychosis but is increased following traumatic events. Rungnirundorn T; Krusong K; Kalayasiri R; Maes M World J Biol Psychiatry; 2022 Oct; 23(8):613-621. PubMed ID: 34895035 [TBL] [Abstract][Full Text] [Related]
36. Clinical features of cocaine-induced paranoia. Satel SL; Southwick SM; Gawin FH Am J Psychiatry; 1991 Apr; 148(4):495-8. PubMed ID: 2006696 [TBL] [Abstract][Full Text] [Related]
37. Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up. Glasner-Edwards S; Marinelli-Casey P; Hillhouse M; Ang A; Mooney LJ; Rawson R; J Nerv Ment Dis; 2009 Apr; 197(4):225-31. PubMed ID: 19363377 [TBL] [Abstract][Full Text] [Related]
38. A questionnaire for the measurement of paranoia/suspiciousness. Rawlings D; Freeman JL Br J Clin Psychol; 1996 Sep; 35(3):451-61. PubMed ID: 8889086 [TBL] [Abstract][Full Text] [Related]
39. Characteristics of Korean patients with methamphetamine use disorder based on the quantitative analysis of methamphetamine and amphetamine in hair. Seo MJ; Song SH; Kim S; Jang WJ; Jeong CH; Lee S Arch Pharm Res; 2020 Aug; 43(8):798-807. PubMed ID: 32737848 [TBL] [Abstract][Full Text] [Related]
40. Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Hoffman WF; Moore M; Templin R; McFarland B; Hitzemann RJ; Mitchell SH Psychopharmacology (Berl); 2006 Oct; 188(2):162-70. PubMed ID: 16915378 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]